Annexon Bioscience's Series B Round

Annexon Bioscience raised a round of funding on June 23, 2016.

Annexon Bioscience is developing therapeutics for neurodegenerative and autoimmune disorders. Specifically, the company is working to develop a pipeline of classical complement pathway inhibitors that…

Articles about Annexon Bioscience's Series B Round: